[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
Browsing: bets
[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha
[ad_1] lcodacci Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to…
[ad_1] Bayer bets $547M on therapies for RNA-driven cancers [ad_2] Source: Seekingalpha